Edwards Lifesciences (EW) Tops Q2 EPS by 6c; Guides Above
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Edwards Lifesciences (EW) Tops Q2 EPS by 6c; Guides Above
July 27, 2016 10:15 AM EDT
Canaccord Genuity analyst Jason Mills reiterated a Buy rating and raised his price target on Edwards Lifesciences (NYSE: EW) to $140.00 (from $132.00) following the latest 'beat and raise'.
Mills commented, ""We view EW as one of the most attractive large-cap growth ideas in... More
July 27, 2016 8:14 AM EDT
UBS analyst Matt Miksic reiterated a Buy rating and boosted his price target on Edwards Lifesciences (NYSE: EW) to $139.00 (from $135.00) following strong results after the close.
Miksic commented, "Our intra-quarter checks indicated strong volume growth, contrary to Street concerns over third-party data indicating otherwise. However, EW delivered results... More
July 27, 2016 7:30 AM EDT
BofA/Merrill Lynch upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Buy with a price target of $130.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $108.35 yesterday.
...
More
